Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
The present study will compare lixisenatide and liraglutide in a population of subjects with
 T2DM not optimally controlled on OADs and / or insulin, which is the target population for
 these medications.
Inclusion Criteria:

 -  Informed consent obtained before any trial-related activities. Trial-related
 activities are any procedures that are carried out as part of the trial, including
 activities to determine suitability for the trial.

 -  Male or female aged 18-65 years (both inclusive)

 -  T2DM diagnosis

 Exclusion Criteria:

 -  Contraindications (including known or suspected hypersensitivity) to GLP-1 mimetics

 -  Use of GLP-1 mimetics or DPP-IV inhibitors

 -  Clinically relevant dysglycaemia as indicated by HbA1C ≥ 10%